Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Cash from Operations (2018 - 2025)

Health Catalyst (HCAT) has disclosed Cash from Operations for 8 consecutive years, with 464000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Operations fell 107.47% year-over-year to 464000.0, compared with a TTM value of 12708000.0 through Sep 2025, down 1230.68%, and an annual FY2024 reading of 14559000.0, up 144.01% over the prior year.
  • Cash from Operations was 464000.0 for Q3 2025 at Health Catalyst, up from 8997000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 10266000.0 in Q1 2024 and bottomed at 19041000.0 in Q4 2023.
  • Average Cash from Operations over 5 years is 4531315.79, with a median of 4845000.0 recorded in 2021.
  • The sharpest move saw Cash from Operations skyrocketed 283.98% in 2024, then tumbled 658.13% in 2025.
  • Year by year, Cash from Operations stood at 9775000.0 in 2021, then plummeted by 51.62% to 14821000.0 in 2022, then decreased by 28.47% to 19041000.0 in 2023, then surged by 81.48% to 3527000.0 in 2024, then surged by 86.84% to 464000.0 in 2025.
  • Business Quant data shows Cash from Operations for HCAT at 464000.0 in Q3 2025, 8997000.0 in Q2 2025, and 280000.0 in Q1 2025.